Improved glycemic control in a diabetic patient after discontinuation of allopurinol administration.
Ohashi
K
K
Ishibashi
S
S
Yazaki
Y
Y
Yamada
N
N
D000493:Allopurinol / Q000009:adverse effects / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D006442:Glycated Hemoglobin / Q000032:analysis; D006029:Glycosuria; D006074:Gout Suppressants / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D014527:Uric Acid / Q000097:blood*
D000493:Allopurinol; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D006074:Gout Suppressants; D007004:Hypoglycemic Agents; D007328:Insulin; D014527:Uric Acid